1. Camilli, Carlotta, Hoeh, Alexandra E, De Rossi, Giulia, Moss, Stephen E, Greenwood, John. 2022. LRG1: an emerging player in disease pathogenesis. In Journal of biomedical science, 29, 6. doi:10.1186/s12929-022-00790-6. https://pubmed.ncbi.nlm.nih.gov/35062948/
2. Hong, Quan, Zhang, Lu, Fu, Jia, He, John C, Lee, Kyung. 2019. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β-Induced Angiogenesis. In Journal of the American Society of Nephrology : JASN, 30, 546-562. doi:10.1681/ASN.2018060599. https://pubmed.ncbi.nlm.nih.gov/30858225/
3. Fu, Zherui, Lai, Yi, Wang, Qianfei, Lin, Feng, Fang, Jiaping. 2023. LRG1 predicts the prognosis and is associated with immune infiltration in thyroid cancer: a bioinformatics study. In Endocrine connections, 13, . doi:10.1530/EC-23-0418. https://pubmed.ncbi.nlm.nih.gov/37991216/
4. Wang, Xuan, Sun, Zeguo, Fu, Jia, He, John C, Lee, Kyung. 2024. LRG1 loss effectively restrains glomerular TGF-β signaling to attenuate diabetic kidney disease. In Molecular therapy : the journal of the American Society of Gene Therapy, 32, 3177-3193. doi:10.1016/j.ymthe.2024.06.027. https://pubmed.ncbi.nlm.nih.gov/38910328/
5. O'Connor, Marie N, Kallenberg, David M, Camilli, Carlotta, Moss, Stephen E, Greenwood, John. 2021. LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency. In Med (New York, N.Y.), 2, 1231-1252.e10. doi:10.1016/j.medj.2021.10.002. https://pubmed.ncbi.nlm.nih.gov/35590198/
6. Park, Han Na, Song, Min Ji, Choi, Young Eun, Chung, Jin Ho, Lee, Seung-Taek. 2023. LRG1 Promotes ECM Integrity by Activating the TGF-β Signaling Pathway in Fibroblasts. In International journal of molecular sciences, 24, . doi:10.3390/ijms241512445. https://pubmed.ncbi.nlm.nih.gov/37569820/
智鼠故事 
